Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from AngioDynamics

AngioDynamics Eyes Growth Despite Tariffs

AngioDynamics, Inc. (NASDAQ:ANGO) posted stronger-than-expected first-quarter results across its Med-Tech businesses and lifted its fiscal 2026 guidance.

Benzinga · Oct 3, 2025

What's Fueling The Momentum In AngioDynamics Stock?

Shares of AngioDynamics, Inc. (NASDAQ:ANGO) are up Thursday after the biotechnology company raised guidance for four key financial metrics and shared positive sales performance for this past quarter.

Benzinga · Oct 2, 2025

AngioDynamics, Globant And 3 Stocks To Watch Heading Into Thursday

With U.S. stock futures trading mixed this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

Benzinga · Oct 2, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings

AngioDynamics, Inc. (NASDAQ:ANGO) will release earnings results for the first quarter, before the opening bell on Thursday, Oct. 2.

Benzinga · Oct 1, 2025

AngioDynamics 'Exceptionally Well-Positioned' For 2026, CEO Says: But Tariffs Still Sting

AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday posted a fourth-quarter 2025 adjusted loss of 3 cents per share, compared to the consensus for a per-share loss of 12 cents.

Benzinga · Jul 15, 2025

AngioDynamics Posts Wider Q3 Loss On Higher Costs, Reaffirms FY22 Outlook

AngioDynamics Inc (NASDAQ:ANGO) has reported a Q3 FY22 adjusted EPS of $0.03, ahead of the consensus of $(0.01), and better than the consensus of $0.02 reported a year ago. Q3 sales increased 3.9% Y/Y to $73.97 million, missing the analyst consensus of $76.32 million. Endovascular Therapies net sales increased 14.5% to $38.1…

Benzinga · Apr 7, 2022

AngioDynamics's Earnings: A Preview

AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Thursday, 2022-04-07. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics will report an earnings per share (EPS) of $-0.01.

Benzinga · Apr 6, 2022

Read news from The Economist, FT, and more,
with one subscription

AngioDynamics's Earnings Outlook

Benzinga · Apr 6, 2022

A Preview Of AngioDynamics's Earnings

Benzinga · Apr 6, 2022

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

419,951 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.